A randomized controlled clinical trial is the best way to minimize bias in ascertaining treatment effects, but the credibility of the results of a trial depends on the validity of the methods used to analyze the data, and the conditions under which such methods produce valid answers. A sensitivity analysis is a method to determine the robustness of trial findings by examining the extent to which results are affected by changes in methods, models, values of unmeasured variables, or assumptions. The goal of a sensitivity analysis is to identify results that are most dependent on questionable or unsupported assumptions. In this article, we briefly review the current use of sensitivity analyses in a random sample of published nutrition literature and provide a guide on the use of sensitivity analyses in randomized trials as to when to consider them, what to consider when planning them, and different methods of implementing them. We propose an 8-step strategy for improving the approach to conducting and reporting sensitivity analyses in nutrition-based trials.
INTRODUCTION
Well-designed and -conducted randomized controlled trials of interventions represent the highest level of evidence of treatment efficacy. The randomized controlled clinical trial, if ethical and possible, is the best way to minimize bias in ascertaining treatment effects. Through random assignment, groups of patients are established with similar distributions of characteristics that could determine their responses to the intervention. If prognostic factors are balanced in the 2 (or more) groups, any differences between the groups in the outcome that are observed can be confidently attributed to the experimental intervention. For this reason, randomized controlled trials are the cornerstone of evidence-based medicine, and the results guide evidence-based health care practices and therapeutic choices to improve patient outcomes.
The credibility of the results of a trial depends on the validity of the methods used to analyze the data and the assumptions under which such methods produce valid answers (1) . If these conditions are not met, the confidence in the results of a trial may be lowered. Examples of factors that may affect confidence in the results of a trial include the method of statistical analysis (2) , deviations from the protocol (i.e., nonadherence) (3, 4) , accounting for the correlation of repeated measures (5, 6) , alternative outcome or treatment definitions (7) , the presence of outliers (8, 9) , high rates of dropout or other forms of missing data (10, 11) , and the potential identification of subgroup effects (12) (13) (14) . An analytic approach to assessing the impact of these factors in the context of randomized controlled trials is known as a sensitivity analysis (SA) 11 (1). An SA is "a method used to determine the robustness of an assessment by examining the extent to which results are affected by changes in methods, models, values of unmeasured variables, or assumptions" (15) . SAs play a crucial role in assessing the robustness of the findings or conclusions on the basis of primary analyses of data in clinical trials, which is a critical way to 1 The authors reported no funding received for this study. 2 Supplemental Material is available from the "Online Supporting Material" link in the online posting of the article and from the same link in the online table of contents at http://ajcn.nutrition.org.
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assess the impact, effect, or influence of key assumptions or variations (such as different methods of analysis, definitions of outcomes, protocol deviations, missing data, and outliers) on the overall conclusions of a study. If the findings of the SA are consistent with those of the primary analysis, this indicates that the findings are robust even if ideal experimental and analytic conditions have not been met, thereby increasing confidence in the results. In this article, we briefly review the current use of SAs in a random sample of published nutrition literature and provide a guide on the use of SAs in randomized trials as to when to consider them, what to consider when planning them, and different methods of implementing them.
WHAT IS AN SA?
An SA is defined as "a method to determine the robustness of an assessment by examining the extent to which results are affected by changes in methods, models, values of unmeasured variables, or assumptions" (16) . The aim of SAs is to identify "results that are most dependent on questionable or unsupported assumptions" (16) .
HOW TO BUILD AN SA INTO THE PROTOCOL
The United States Food and Drug Administration offers guidance on statistical approaches to clinical trials and emphasizes that "it is important to evaluate the robustness of the results and primary conclusions of the trial" (17) . Therefore, it is wise, at the protocol stage, to think carefully about the primary analytic approach as well as alternative approaches to the data analysis that might reasonably be used and assumptions under which the validity of the primary analysis plan may be questionable. For example, an SA to confirm the impact of modeling assumptions should be considered at this stage and thoughtfully planned out.
Some considerations that could be addressed when planning SAs include whether there are viable alternative ways of measuring the outcome; whether there are multiple statistical analytic approaches that could be used in a valid manner to address the same research question; what is the anticipated missing data mechanism, and what would be the best way to account for missing data in the trial; how influential are minor deviations from the protocol; and the distribution of the variables and the possibility of outliers. Appropriate consideration should be given to collecting sufficient data on each of these factors to facilitate informative SAs that assess the influence of the variation in each factor on the robustness of the main analysis.
For example, the PREDIMED (Prevención con Dieta Mediterránea) trial was a parallel-group, multicenter, randomized trial of a Mediterranean diet for the primary prevention of cardiovascular disease. Under ideal conditions, the effect of the diet on the rate of occurrence of events would 1) be constant over time, 2) be similar for all cardiovascular outcomes, 3) not differ according to study center, and 4) have no participants lost to follow-up. However, such assumptions are reasonably questionable; therefore, the authors presented SAs for different ways of handling missing data points (complete case, single imputation, and multiple imputation), different outcome definitions (including angina plus revascularization as a composite endpoint), variations in results by recruitment site (excluding centers with atypically low or high event rates), and the time course of the effect of the intervention effect (by excluding events occurring early or late) (18) .
HOW OFTEN ARE SAs REPORTED IN PRACTICE?
To determine the use and reporting of SAs in the field of nutrition research, we reviewed the tables of contents of the following 8 leading journals in the field of nutrition and dietetics from 1 January 2013 through 20 March 2015: The American Journal of Clinical Nutrition, the Journal of the American College of Nutrition, the Journal of the Academy of Nutrition and Dietetics, the Journal of Nutrition, the Journal of Parenteral and Enteral Nutrition, Appetite, the European Journal of Clinical Nutrition, and the Journal of Nutritional Biochemistry. We identified 184 reports of randomized controlled trials of which we reviewed 100 reports in detail that were selected at random (Supplemental Material). Of the 100 included articles, 40 articles were published in 2013, 49 articles were published in 2014, and 11 articles were published in 2015. The trials were conducted in 29 countries; studies conducted within the United States contributed the most trials of any single country (n = 29 articles). The majority of the trials were published in The American Journal of Clinical Nutrition (n = 56) followed by those published in the Journal of the American College of Nutrition (n = 17), the Journal of the Academy of Nutrition and Dietetics (n = 10), the Journal of Nutrition (n = 5), the Journal of Parenteral and Enteral Nutrition (n = 4), Appetite (n = 3), the European Journal of Clinical Nutrition (n = 3), and the Journal of Nutritional Biochemistry (n = 2).
Of the 100 randomly selected studies, 18 studies reported having conducted SAs ( Table 1) . The sensitivity approaches documented included the impact of noncompliance or protocol deviations (n = 11), the impact of missing data (n = 4), the impact of competing risks in a trial of composite outcomes (n = 1), the impact of a baseline imbalance (n = 1), the impact of prognostic factors (n = 1), and the impact of different assumptions underlying the statistical model (n = 1) ( Table 2) . Eighteen studies reported having performed one or more SAs. Of these 18 studies, 5 studies reported having planned the SAs a priori, and 6 studies reported post hoc SAs. In 7 of the studies, it was unclear whether the SA was conducted a priori or post hoc.
Fifteen of the 18 studies (83%) reported the final results on the basis of the original findings, whereas 3 studies (17%) reported results on the basis of the SAs (Table 3) . Eleven studies (61%) showed significant results [i.e., the between-treatment difference in response was declared of statistical significance at the specified a level (e.g., P , 0.05)] in the primary analyses, and 7 studies did not (39%) report significant results in the primary analyses. In 2 of the 11 studies (18%) that reported significant results from the primary analyses, the SAs were nonsignificant, and in one of the 7 studies (14%) that did not report significant results in the primary analyses, the SAs were significant. Six of 18 studies that performed SAs (33%) mentioned the SAs in the final conclusion.
AN OVERVIEW OF COMMON SAs
We describe some of the major SAs encountered in nutrition trials with reference to examples drawn from the nutrition literature. Examples of these SAs from the literature are listed in Table 4 .
Impact of nonadherence or protocol deviations
In nutrition trials, interventions may be delivered in several ways, ranging in intensity from dietary advice that participants follow in a free-living setting to supermarket models in which participants receive all foods free of charge for 3-6 mo from a hospital-or university-based supermarket, and the diet composition is controlled by the bar codes and a computer program, to controlled-feeding studies in which all study food is provided and eating occasions are monitored, and to metabolic ward studies involving admission to a unit for observation during which time all food intake and waste output is carefully measured. Adherence is often suboptimal in advice-only trials (19, 41) and much better in supermarket studies (42) , controlled-feeding studies (43, 44) , or metabolic ward studies (45, 46) . Incomplete adherence to the assigned intervention poses several challenges for interpretation and may leave a trial underpowered to detect the planned effect size.
In most randomized controlled trials, the preferred approach to the primary analysis is to follow the intention-to-treat (ITT) principle in which all participants who are randomly assigned are analyzed according to their assigned study group (the maxim "as randomized, so analyzed") ignoring the degree of adherence, deviations from protocol, or the fact that some participants are lost during follow-up (47) . This analysis plan preserves the unique advantage of the randomized trial design (i.e., the balancing of known and unknown confounders) and avoids presenting biased or optimistic estimates of treatment effects on the basis of only those individuals who are highly adherent to the study protocol. It is important to distinguish high trial retention from high dietary adherence. The former refers to participants attending a high proportion of study measurement visits, whereas the latter refers to participants who actually consume a high proportion of the food they are assigned to consume. One does not necessarily imply the other; e.g., in the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) randomized trial, participant retention was very high (80% over 2 y), but adherence to assigned macronutrient ranges was suboptimal (19, 48) .
The following 2 SAs are often performed in addition to the ITT analysis: a per protocol analysis, in which participants who do not adhere to the assigned intervention are excluded from the analysis set, and an as-treated analysis, in which participants are analyzed according to the treatment they actually took during the study (49) . Although standard approaches to handling missing data because of poor retention are suitable for nutrition trials, methods of approaching poor dietary adherence are less straightforward. In trials of whole diets, clear as-treated analyses are seldom feasible because participants are rarely totally nonadherent or fully adherent, but adherence to desired dietary interventions may be as low as 50-60% in advice-only, long-term studies (19) but may reach as high as .90% (50) when food is provided in shorterterm studies. A common approach to an as-treated analysis in these trials is to relate adherence to the effect size. In a randomized trial of a dietary portfolio approach to cholesterol reduction, adherence to the 4 emphasized dietary portfolio components (nuts, soy, viscous fiber, and plant sterol) was regressed on the LDL-cholesterol change and was shown to be significantly associated with the percentage reduction in LDL cholesterol in participants who completed the study (51) . This sensitivity or explanatory analysis showed that the effectiveness of the intervention was directly related to the degree of adherence to the diet prescribed.
Impact of outliers
Outliers are observations that are not representative of the sample population enrolled in the study and typically present a value .2 SDs from the group mean or also on the basis of face validity [e.g., BMI (in kg/m 2 ) .50.0] or clinical reasons (e.g., fasting glucose concentration .7.0 mmol/L in participants without diabetes) (52) . Such implausible data points may unduly influence the statistical model, particularly in studies with a small sample size. Care should be taken to ensure outlying values are true outliers and not simply a result of a clerical error. The most-comprehensive and transparent approach is to present analyses both with and without outlying values and to assess the robustness of the main analysis as to the presence or absence of these extreme cases. However, if the outliers are not clerical errors and are not from a different population than the sample, there is no compelling reason to exclude them from the analysis.
Thus, a third possibility to dealing with outlying values is robust regression, which offers a compromise between excluding these points entirely from the analysis and including all the data points and treating all of them equally in a regression model. Robust regression is an alternative to ordinary least-squares regression in the presence of outliers or influential observations, and it can also be used to detect influential observations. The idea of robust regression is to weigh the observations differently on the basis of how closely an observation fits the regression line. Simply put, values with large deviations from the line of best fit (i.e., with large residuals) are given less weight in the regression analysis. As the absolute value of the residual decreases, the weight of the observation is increased.
This approach was used in a study of weight changes over 1 and 2 y in 303 women enrolled in a low-fat dietary-intervention trial. A multivariable regression analysis was used to quantify the independent predictive values of changes in energy and the percentage of energy from fat on the change in body weight (29) . The primary analysis used ordinary least-squares regression. No effect of energy reduction was seen once the effect of dietary fat was controlled for. SAs that 1) excluded 22 women with outlying values for weight change and 2) used robust-regression approaches that used all observations but minimized the influence of outliers by systematically downweighting them were undertaken. The magnitude of the regression coefficients were sensitive to the regression-modeling approach, but all sensitivity approaches supported the primary analysis and showed that the change in the percentage of energy from fat was strongly and significantly associated with the change in body weight.
Impact of missing outcome data
Missing data, which is loosely defined as "missing some information on the phenomena in which we are interested" (53) , is a widespread problem in clinical research. Our review of 100 articles in the field of nutrition showed that 14% of articles reported .20% of missing outcome data; 34% of articles reported $10% of missing outcome data; and 52% of articles had $5% of missing data. In total, 92% of trials had some missing data on the primary outcome. This finding is compatible with a recent review of musculoskeletal randomized trials that showed 95% (of 91 trials) reported at least some missing outcome data (54) .
Several mechanisms give rise to missing data, and the most appropriate analytic approach in the presence of missing data is dependent on the pattern of the missingness. The 3 common missing data mechanisms are missing completely at random (MCAR), missing at random (MAR), and missing not at random (MNAR). When data are MCAR, participants with missing outcome data are accepted to represent a random sample of all enrolled participants (picture the case in which a box of participant records is inadvertently shredded in confidential waste). When data are MAR, the missing data are dependent on other observed values (picture a study in which younger participants are more likely to not attend a clinic visit than older participants are; the pooled analysis of completers will be biased toward the result in older participants, but analyses stratified by age will still be valid). A more-serious problem arises when data are MNAR, the so-called nonignorable missing data; in this case, the missing data are dependent on a process that resulted in the value being missing (picture a participant who fails to provide a final vitamin D sample in a trial of vitamin D supplementation because they did not attend their final visit because of nausea from the supplement). In a 2-arm, parallel trial to determine whether calcium carbonate supplementation would reduce BP in Gambian women, the primary analysis comparing BP between treatment and placebo groups with the use of completers only was supplemented with an as-treated analysis that related the number of tablets a women consumed to her BP at week 36. In the as-treated analysis, there was no significant difference between calcium and placebo groups in the change between 20 and 36 wk of gestation in SBP (20) . Per-protocol analysis In a 2-arm, parallel trial to determine the safety and efficacy of vitamin D to improve markers of insulin sensitivity and resistance and reduce inflammation, the primary analysis (ITT) was supplemented with an analysis with the use of only data form participants who completed all 3 expected study visits. Results were similar in magnitude and direction (21) . 2 In a 3-arm, parallel trial to determine whether fortified juices increased vitamin concentrations in children, the primary analysis (with the use of all available data from each participant; the analysis sample) was supplemented with an analysis that carried forward missing values or replaced missing values with the mean of all participants (ITT).
Results were not significantly different from those of the analysis sample (22) . 2 In a 2-arm, parallel trial to determine whether replacing refined grains with whole grains in the context of a weight-loss intervention would improve MetS criteria in individuals with or at risk of MetS, the primary analysis (with the use of linear mixed models; all-available data) was supplemented with an analysis that removed noncompliant individuals (n = 3 of 60; 5%). Results showed a stronger effect of the intervention on glucose [difference of 4.1 mg/dL (P = 0.02) vs. 3.3 mg/dL (P = 0.03)] (23). 2 In a 2-arm, parallel trial to determine whether protecting parenteral nutrition solutions from light decreases the rate of bronchopulmonary dysplasia or death in very-low-birth-weight infants, the primary analysis did not show significant beneficial effects of photoprotection (with the use of nonlinear mixed models; all available data). A sensitivity analysis used a per-protocol analysis with the exclusion of infants in whom the intervention was not delivered as intended (n = 45; 8% missing data). Results of the per-protocol analysis were similar to those obtained with the ITT analysis (24). 2 In a 2-arm, parallel trial of probiotics in obese pregnancy to reduce maternal fasting glucose, no differences in metabolic variables were noted in an ITT analysis. No significant difference was found in any outcome between intervention and control in the main analysis. In a sensitivity analysis, noncompliers (n = 21; 15%) and antibiotic users during the study (n = 6; 4%) were excluded. The sensitivity analyses showed no differences in any outcome between intervention and control groups (25) . 2 In a randomized, balanced, crossover study to test the satiating value of aerated drinks with differing gastric stabilities, 3 skim-milk-based test products were consumed and compared with respect to self-reported appetite ratings. Compared with the control, both aerated drinks increased the gastric volume and reduced hunger with the use of a mixed model with all available data at each time point (ITT). Three participants did not complete the study after starting (17%). Both ITT and per-protocol populations were analyzed, and both groups yielded similar results and conclusions. Only ITT results were presented (26) . 2 In a 4-arm, parallel, factorial design, the effect of cocoa and theobromine on serum HDLcholesterol concentrations was examined. The full-set analysis included all subjects for whom end-of-intervention values were available. A per-protocol analysis excluded data from participants who were noncompliant with test-product consumption (n = 9; 6%; defined as ,80% of the total prescribed intake; included subjects who had a body weight change .2 kg or who did not follow dietary restrictions). The per-protocol analysis and full-set analysis showed similar results; only the results of the full-set analysis were presented (27) . Outliers Robust regression In a study of weight changes over 1 and 2 y in 303 women enrolled in a low-fat dietary intervention trial, a multivariable regression analysis was used to quantify the independent predictive values of changes in energy and the percentage of energy from fat on the change in body weight The primary analysis used an ordinary least-squares regression. No effect of energy reduction was seen once the effect of dietary fat was controlled for. Sensitivity analyses that 1) excluded 22 women with outlying values for weight change and 2) used robust-regression approaches that used all observations but minimized the influence of outliers by systematically downweighting them were undertaken. The magnitudes of the regression coefficients were sensitive to the regression-modeling approach, but all sensitivity approaches supported the primary analysis and showed that the change in the percentage of energy from fat was strongly and significantly associated with the change in body weight (29) . 2 Missing data Analyze only completers data In a 4-arm, 2 3 2 factorial RCT of macronutrient composition and weight loss, an ITT analysis in which long-term weight loss for persons who withdrew from the study early (after $6 mo of participation) was imputed on the basis of a rate of 0.3 kg regained weight/mo and a rate of 0.3 cm regained waist circumference/mo after withdrawal. The main analysis showed no significant differences in weight changes according to the assigned macronutrient over 2 y. In a 3-arm, parallel RCT to determine whether manipulating the glycemic index of the diet resulted in improved weight loss, the primary analysis was by ITT, which included all randomly assigned participants with the use of the LOCF to replace missing data points (single imputation). At weeks 16, 20, and 24, decreases in BMI were higher in the lowglycemic index-diet group than in the low-fat-diet group. The per-protocol analysis excluded individuals who did not attend the final visit (n = 17 of 122; 14%). Results at 6 mo (24 wk) in the per-protocol analysis were similar to that of the ITT analysis (30).
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In a 2-arm, double-blind, parallel RCT of perioperative probiotic treatment on serum zonulin concentrations and postoperative infectious complications after colorectal cancer surgery, the probiotics group, compared with the placebo group, had a lower postoperative serum zonulin concentration and postoperative infection rate. A per-protocol sensitivity analysis was conducted including only subjects who completed the trial (excluding n = 13; 9%). Similar results were showed in the per-protocol data (31).
In a 3-arm, parallel RCT of mobile technology to monitor physical activity and nutrition over 12 mo in patients with MetS, 3 approaches to handling missing data were presented. The primary analysis used the mixed-model approach with all available data at each time point. Sensitivity analyses used the following 3 methods of imputation of outcomes for dropouts (n = 43; 23%): LOCF, BOCF, and multiple imputation. Dropout rates were not equal across groups (36% in the control arm; 16% in the ABC arm; 18% in the 4S arm). The sensitivity analysis suggested that lost cases were those with the smallest weight loss (3.7 kg in control for the mixed-model approach, 3.0 kg for the LOCF, and 2.5 kg for the BOCF); results from control subjects who completed the study likely overestimated the true effects (32).
In a 2-arm, parallel RCT of a low-glycemic index diet vs. a low-fat diet on body composition and components of MetS in obese Hispanic youth, the primary analysis used a multipleimputation approach of dealing with missing data with the assumption of missing-atrandom data and not-at-random data. Predictors of BMI change were used to inform the imputation as follows: BMI, age, sex, maternal education, and waist circumference at baseline. A sensitivity analysis used only completers and yielded similar results (33). 2 In a cluster-randomized trial that appropriately accounted for clustering, the impact of a short term (,6 mo) telephone intervention aimed at improving children's fruit and vegetable intake on longer-term fruit and vegetable intake was examined in a cluster-randomized controlled design. The primary endpoint was fruit and vegetable intake at 18 mo after baseline. The primary analysis used generalized estimating equations to assess efficacy with the use of all available data at 18 mo. At the 12-mo follow-up, Children's Dietary Questionnaire fruit and vegetable subscale scores were significantly higher in children in the intervention group, indicating greater child fruit and vegetable intake. Sensitivity analyses to deal with missing data included 1) baseline carried forward and 2) subgroup analyses by parent socioeconomic status and educational attainment to assess the consistency of the main findings across subgroups. The effect remained significant when In the Childhood Obesity Project, a 2-arm, randomized trial was conducted of higher-vs. lower-protein formulas within the first year of life on the development of obesity. The primary outcome was the BMI z score at 6 y, and the treatment difference was assessed with the use of a linear regression without adjustment for covariates. Several sensitivity analyses were performed as follows: 1) Adjustment was made for potential confounders (sex, age at measurement, country, highest education level of the mother and father, smoking during pregnancy, and mother and father BMI); 2) To test for the effect of missing data (98 children did not have measured BMI; 13%), the 6-y analysis also included a parental report of weight and height at 6 y via telephone; and 3) The imputation of missing values was conducted with the use of chained equations. When missing values were replaced by values from telephone interviews and multiple imputations, the estimated effects decreased (35) . 2 Baseline imbalance Analysis with and without adjustment for baseline
In a 2-arm, parallel trial of probiotics in obese pregnancy to reduce maternal fasting glucose, an imbalance of baseline BMI (in kg/m 2 ) was noted between the probiotic and placebo groups (32.9 6 2.4 vs. 34.1 6 2.7; P = 0.007). Thus, the authors performed "an additional analysis of primary and secondary outcomes [.] by using the general linear model with BMI as the covariate and intervention as the fixed factor," but the article and accompanying materials presented only the models adjusted for baseline BMI (25) . 2 
Stratify the analysis according to prognostic values
In a 2-arm, parallel trial of normal protein intake vs. moderate protein intake on renal function, which was measured as the change in eGFR, the primary analysis was by ITT according to assigned groups. Changes in eGFR were shown to be related to the baseline eGFR. A post hoc analysis was performed and stratified by baseline eGFR. In this sensitivity analysis, participants with stage 1, 2, or 3 renal disease (less-severe disease) had improved renal function with weight loss; those with hyperfiltration (more-severe disease) had worsened renal function with weight loss (36). 2 Various methods of adjustment: multivariable regression and propensity score matching (more common in observational studies)
In a double-blind, placebo-controlled trial of vitamin B-12 supplementation for neurologic and cognitive function in moderately vitamin B-12-deficient older adults, the primary analysis, which was adjusted for baseline neurologic function (with the use of an ANCOVA), showed no evidence of an effect of supplementation on the primary outcome of the posterior tibial compound muscle action potential amplitude at 12 mo. A sensitivity analysis, which used an ANCOVA to adjust for age and sex in addition to baseline neurologic function, showed virtually identical effect sizes and did not change the main analysis result (37).
Definition of outcomes Perform analyses on outcomes of different cutoffs or definitions
In the Physicians Health Study II randomized trial of vitamin E or vitamin C supplementation and prostate cancer, 356 incident cases of prostate cancer were observed over a mean of 2.8 y after the trial ended (10 y of supplementation). In this study, the primary analysis, with the use of a Cox proportional hazards model, showed neither vitamin C nor vitamin E to be significantly better than a placebo for preventing total cancer, prostate cancer, or other sitespecific cancers. Two sensitivity analyses were conducted as follows: 1) participants were censored at the last date of follow-up and 2) an analysis was conducted that was limited to posttrial cancers that were new (i.e., that occurred in men who did not have a cancer at the same site during the intervention period). The results did not materially change (38) . 2 In the POUNDS LOST study, the primary outcome was the mean change in body weight; a sensitivity analysis also examined differences in the proportions of participants achieving a threshold of weight loss that was deemed to be clinically important. For example, at 2 y, 31-37% of the participants had lost $5% of their initial body weight, 14-15% of the participants in each diet group had lost $10% of their initial weight, and 2-4% of the participants had lost $20 kg (P-comparisons between diets . 0.20). The lack of differences between diets in the proportion of people achieving these targets was consistent with the primary analysis (19).
Distributional assumptions Parametric vs. nonparametric
We did not identify an article in the leading nutrition journals that analyzed the same data with the use of both parametric and nonparametric approaches; typically, one of the 2 approaches was used. In a study of the effectiveness of nutrition therapy in pediatric patients with chronic liver diseases awaiting liver transplantation, one group of children were assigned an intensive nutrition protocol (oral diet plus enteral nutrition), and the other group was assigned an oral diet alone. Comparisons between height z scores in girls were made with the use of an independent-samples t test and a Mann-Whitney U test. In the t-test approach, the height z score was 1.16 U higher (95% CI: 0.09, 2.23 U higher) in children receiving
Unfortunately, in practice, missing data rarely arise from a single mechanism, and it is impractical, if not impossible, to distinguish among the missing data mechanisms. The only true way to distinguish between MNAR and MAR is to measure some of that missing data. For example, one could contact a group who withdrew from the study and ask a few key questions about variables of interest in the study (e.g., weight or the number of fruit eaten in the past week). This method would allow for a comparison of respondents to nonrespondents on some key characteristics. If the responses between subjects who withdrew and those who remained in the study differ substantially, this difference is evidence that the data are MNAR.
An MCAR mechanism can be detected with the use of Little's test (55) or by creating dummy (indicator) variables for whether a variable is missing (1) or observed (0) at a planned measurement occasion. A chi-square test can be used to assess whether the proportion of missingness on the variable is related to observed values of other variables. For example, the differences in the percentages of missing values for the outcome of body weight between athletes and nonathletes in a study of weightmanagement practices in college students could be compared, and a significant chi-square test may reveal that the percentage of missing data for weight is higher in nonathletes.
The best way to handle missing data is to take all of the steps possible to avoid missing data during the study design phase by designing a protocol that is highly acceptable for enrolled participants. Little et al. (11) provided an excellent review of the prevention and treatment of missing data in clinical trials. Missing data points may also be partially recovered. For example, in a weight-loss trial, participants who drop out of a trial may be asked to return for one final weigh-in visit (56, 57) or telephoned and asked to weigh themselves on a home scale; or in a blood pressure-reduction trial, participants who drop out may be asked to share the most-recent blood pressure measurement taken by their family physician.
There are 2 general approaches to handling missing data during the analysis phase as follows: imputation-based methods (single or multiple) and likelihood-based methods. Singleimputation methods are most commonly used, such as the baseline observation carried forward where baseline values of participants replace unobserved values (58), the last-observation carriedforward method where the observation at the time point closest to the missing value replaces the unobserved value (59), mean imputation where the mean of observed values for other participants replaces the unobserved values (60), or a regression approach where the predicted value for an individual of, e.g., the same age, sex, or random assignment replaces the unobserved values. Although computationally straightforward, single-imputation methods generally lead to biased estimates of the treatment effect and underestimate the variability. The last observation carried forward may be particularly misleading when changes in the outcome measure tend to be more pronounced early in a study with a gradual regression to the mean, which is typical of weightloss interventions (10) .
Less biased but more-computationally intensive approaches to handling missing data are also available. For example, multiple imputation fills in all missing values m times chosen at random from a distribution of values thereby creating m new, complete pseudo-data sets. These m complete data sets are analyzed, and the results are pooled with the between-imputation and withindata set variation taken into account (61) . If data are assumed to be MAR, mixed models (62), generalized estimating equations (for continuous data) (63) , or generalized linear mixed models (for count or binary data) (64) can be used to generate variable estimates with the use of all available data.
For example, in the PREDIMED trial (18) , all primary analyses were performed under the ITT principle. Time-to-event data were analyzed with the use of Cox models. SAs were conducted by imputing data for missing values, and participants who dropped out (523 of 7447 randomly assigned subjects; a 7% loss to follow-up). In the primary analysis, the HR for the comparison of a Mediterranean diet supplemented with extravirgin olive oil with a control diet was 0.70 (95% CI: 0.53, 0.91), and the HR for the comparison of a Mediterranean diet supplemented with nuts with a control diet was 0.70 (95% CI: 0.53, 0.94). In SAs with the use of the complete-case analysis, the HRs became 0.69 and 0.70, respectively; with the use of single imputation, the HRs became 0.70 and 0.72, respectively; and with the use of multiple imputation, the HRs became 0.67 and 0.70, respectively.
In the POUNDS LOST trial (19) , all primary analyses were performed under the ITT principle. Mean weight loss was In a longitudinal study of a daily lipid-based nutrient supplement for increased linear growth in young children, healthy infants were assigned to either a control or a 3-or 6-mo supplementation period of vitamin A, vitamin B-12, iron, and zinc. The effect of the intervention was modeled with the use of a generalized-least squared model with random effects and mixed effects (random plus fixed effects). The mixed model was chosen for analysis because assumptions for random effects were not justifiable (i.e., individual effects were uncorrelated with the independent variables, and dropout was at random) (40). analyzed with the use of unpaired t tests between groups on the change from baseline values in body weight. In this study, longterm weight loss for persons who withdrew from the study after $6 mo of participation (n = 166 of 811; 20%) was imputed on the basis of a rate of 0.3 kg regained weight/mo after withdrawal. The difference in weight change over 2 y between highand usual-protein groups was 20.6 kg (95% CI: 21.6, 0.4 kg; P = 0.22, n = 811) with the use of the ITT approach and 20.9 kg (95% CI: 22.1, 0.2 kg; P = 0.10, n = 645) with the use of the completers-only approach. In the subset of participants with a body composition analysis, the dropout rate was twice as high as reported for the main trial (n = 188 of 424; 44%) (65) . In the ITT analysis, the baseline body fat percentage was applied to the imputed weight to estimate fat and lean mass at the missing time point. The difference in the change of body fat over 2 y between high-and usual-protein groups was 20.5 kg (P = 0.30, n = 424) with the use of the ITT approach and 20.1 kg (P = 0.90, n = 236) with the use of the completers-only approach.
These examples serve to illustrate that, when the proportion of missing data is expected to be small and nondifferential (as in the PREDIMED trial), the choice of methodology to deal with missing data may be relatively inconsequential; however, when the proportion of missing data is expected to be large (as was planned for in the POUNDS LOST trial), missing-data approaches must be carefully considered.
UNDER WHAT GENERAL CONDITIONS IS A COM-PLETE-CASE ANALYSIS APPROPRIATE?
When the proportion of missingness is low and in similar proportions within each randomly assigned group, the impact of the choice of method of handling missing data (e.g., completecase compared with imputation methods) is not likely to change the conclusions of an ITT analysis. Complete-case analyses are also useful in pilot or efficacy (does it work?) trials. In efficacy trials, the goal is to determine whether the intervention worked under ideal circumstances in an ideal resource-intensive setting and in a highly selected, homogenous population who are cared for by a highly experienced and well-trained team who strictly enforce and standardize the intervention, and there is no contamination (66) .
UNDER WHAT GENERAL CONDITIONS IS A COM-PLETE-CASE ANALYSIS INAPPROPRIATE?
When the proportion of missingness is high (i.e., .30%) or not equally distributed between randomly assigned groups, careful attention must be paid to the treatment of missing data. Under conditions of nonignorable missingness (MNAR), a complete-case analysis should be interpreted with a great deal of caution and preferably avoided because there is no optimal way to arrive at an unbiased answer in the presence of nonignorable missing data. When data are MCAR or MAR, multiple imputation-based methods provide efficient answers even when the degree of missingness is high (67) . An ITT approach is the preferred approach for effectiveness trials (68) . In effectiveness trials, the goal is to determine whether the intervention will work in a real-world setting in a typical clinic with a heterogeneous population representative of the people who will use the intervention and are cared for by representative, usual providers who allow flexibility with respect to the intervention and for concurrent interventions and possible crossover (66) .
Impact of baseline imbalance
The major advantage of a randomized trial for causal inference is that random assignment balances known and unknown confounders; if the random assignment is performed correctly, treatment effects can be attributed to the intervention. However, a residual imbalance in baseline measures of the outcome or important covariate (e.g., age, BMI, or sex) may occur by chance. An ANCOVA (i.e., including the baseline value of the outcome measure or covariate) may yield more-precise estimates of the treatment effect (25, 37) .
To avoid the possibility of an imbalance, block randomization is a commonly used technique in clinical trial design (69) . This approach increases the probability that each arm will contain an equal number of individuals by sequencing participant assignments into small groups called blocks, and within a block, there is a balanced allocation. Although this approach is helpful to ensure a balance, the allocation process may be predictable (e.g., when the investigator is not blind, and the block size is fixed). For example, in a 2-group parallel trial with a fixed block size of 4, after 2 participants are allocated to arm 1, the investigator can predict that the next 2 assignments will be to arm 2. Selection bias may be reduced with the use of random block sizes and keeping the investigator blind to the size of each block (e.g., some of 2, some of 4, and some of 8).
Impact of outcome definition
Often an outcome is defined by achieving or not achieving a certain level or threshold of a measure. For example, in a study measuring adherence rates to medication, levels of adherence can be dichotomized as achieving or not achieving $80%, $85%, or $90% of pills taken. The choice of the level a participant has to achieve can affect the outcome, whereby it might be harder to achieve 90% adherence than 80% adherence. Therefore, an SA could be performed to see how redefining the threshold changes the observed effect of a given intervention.
In the POUNDS LOST study, the primary outcome was the mean change in body weight; an SA also examined differences in the proportions of participants who achieved a threshold of weight loss that was deemed to be clinically important. For example, at 2 y, within each diet group, 31-37% of participants had lost $5% of their initial body weight, 14-15% of participants had lost $10% of their initial weight, and 2-4% of participants had lost $20 kg (P-comparisons between diets . 0.20) (19) . This recasting of the outcomes did not affect the conclusions of the primary analysis.
In the Physicians Health Study II randomized trial of vitamin E or vitamin C supplementation and prostate cancer, 356 incident cases of prostate cancer were observed over a mean of 2.8 y after the trial ended (10 y of supplementation). In this study, the primary analysis, with the use of a Cox proportional hazards model, showed neither vitamin C nor vitamin E was significantly better than a placebo for preventing total cancer, prostate cancer, or other site-specific cancers. Two SAs were conducted as follows: first, participants were censored at the last date of followup; and second, an analysis that was limited to posttrial cancers that were new (i.e., that occurred in men who did not have a cancer at the same site during the intervention period). The results did not materially change (38) .
Impact of distributional assumptions
Many statistical analyses depend on normally distributed continuous outcomes; binomially distributed dichotomous outcomes; or Poisson-distributed count outcomes, negative binomial distributions, or zero-inflated negative binomial distributions. Goodness-of-fit tests can help assess departures from the underlying distribution required for the chosen test (70) . SAs may invoke nonparametric tests to test the robustness of the primary analyses assuming distributional assumptions are met ( Table 5 reviews some common nonparametric analogs of parametric tests; we suggest a discussion of these alternatives with an experienced statistician during the development of an analysis plan).
HOW TO INTERPRET SAs
When the primary analysis and all SAs provide similar estimates of the magnitude and direction of treatment effect, similar P values, and similar widths of CIs, one can be reasonably confident that the finding of the trial is robust. A brief statement to this effect may suffice.
When the primary analysis and SAs differ, the situation is more difficult. Our guidance in this situation is to remember that the goal of an SA is not to select the best results. Rather, the aim is to assess the robustness or consistency of the results under, e.g., different methods, subgroups, definitions, and assumptions. The assessment of robustness is often based on the magnitude, direction, or statistical significance of the estimates. A sensitivity analysis cannot be used to choose an alternative conclusion to a study. Authors should state the conclusion on the basis of the primary analysis plan and use the presentation of one or more sensitivity analyses as a way of assessing the robustness and validity of the primary analysis. If the SA suggests that the primary analysis is not robust, it may point to the need for future research that might address the source of the inconsistency. To answer the question of which method is best and under what conditions, simulation studies comparing the different approaches on the basis of bias, precision, coverage, or efficiency may be necessary.
A common interpretation of SAs in nutrition trials is to distinguish relative efficacy from the effectiveness of an intervention. An efficacy study aims to determine whether the intervention works under ideal circumstances; an effectiveness study aims to determine whether the intervention works in real-world practice (66) . For example, an analysis of only those individuals who completed a dietary intervention trial and achieved a high level of adherence (e.g., took close to all of the prescribed diet or supplement) would provide the best estimate of an intervention's efficacy (i.e., did it work under ideal circumstances?). An ITT analysis, with the use of all If the distribution is assumed to have a finite first moment and is symmetric about the median, the 2 null hypotheses (for parametric and nonparametric tests) are the same. randomly assigned participants (i.e., as they were randomly assigned, regardless of whether they consumed close to or all of the prescribed diet or supplement) would provide the best estimate of an intervention's effectiveness (i.e., did it work in the real world?). For example, if a completers-only analysis shows that a dietary intervention reduces serum cholesterol, but the ITT analysis finds no effect of the intervention on cholesterol, we could say that the intervention is efficacious but not effective for a population intervention.
WHEN AND HOW SHOULD I REPORT AN SA?
A priori, planned SAs should be written into the study protocol and described in the Methods section of a manuscript. Post hoc SAs should be clearly identified as such, and the rationale for such analyses should be clearly justified. For example, if the dropout in a study is large and higher than anticipated when the power and sample size for the study was determined (57) , there may be a sufficient dilution of the intended treatment effect such that the ITT analysis is underpowered.
The Methods section of a manuscript should describe the conduct and rationale for all a priori SAs outlined in the statistical analysis plan as well as for all post hoc SAs conducted. The results of all a priori and post hoc SAs should be reported. It may be sufficient to state that the SAs were conducted but did not yield materially different conclusions; and these data could be presented in summary form as supplemental material. If an SA yields results that are substantially different from that of the primary analysis plan, the results of the SA should be reported in the Results section to allow a reader to moredirectly compare these results with those of the primary analysis plan.
It is important that, when an SA yields substantially different conclusions than those of the primary analytic approach, the Discussion section of a manuscript should mention the SA, and the limitations and implications of the findings are discussed. The impact of the SA on the interpretation of the data should be discussed in a context that allows readers to assess whether the primary analysis or SA is more believable or applicable to their practice and how the assumptions of the SA differ from that of the primary analysis plan.
In one case (of 18 cases), a post hoc SA replaced the prespecified analysis, and the prespecified analysis was not presented in the main text or supplemental material (25) . We suggest that this practice be avoided and that the primary specified analysis plan be followed. 
A MULTIPLE-STAGE APPROACH TO SAs
We propose an 8-stage process for planning, conducting, and reporting SAs in randomized controlled trials in the field of nutrition (Figure 1) . At the study-design phase, a primary analysis plan should be clearly laid out with careful thought from statisticians, methodologists, and subject-matter experts given to potential variables or analytic methods that are likely to be most sensitive to changes in the methods, models, values of unmeasured variables, or assumptions (stage 1). After these have been identified, SAs should be planned that address the impact of each of the identified variables on the results provided by the primary analysis (stage 2). We believe that these 2 steps, which are performed before any data are collected, are the most crucial to ensure the highest validity of SAs. At the data-analysis phase, with a clear analysis plan prespecified and all data collected, the primary data-analysis plan should be executed (stage 3). After execution of the primary analysis plan, one or more SAs that address the alternative scenarios under which the primary analysis results may change, as prespecified in stage 1 and planned in stage 2, should be carried out (stage 4). We recommend that, in all cases, the primary analysis plan should be reported (stage 5). SAs performed should also be reported (stage 6). We recommend that the results of any preplanned SAs be reported in published articles either in the main text or as supplemental online content. The Discussion section of article should provide the context for the SAs and propose reasons for any discrepancies between the primary results and the results of the SAs (stage 7). Finally, a brief statement should be made about the impact of SAs on the conclusions of the study (stage 8).
In summary, in this article, we provide an overview of the use of SAs in randomized trials in the nutrition literature and provide examples of different types of SAs that might be considered when designing a randomized controlled trial. The reporting of SAs in nutrition is infrequent and suboptimal, and we propose an 8-step strategy for improving the approach to SAs and to facilitate transparency in reporting.
